1. Home
  2. AVDL vs VLRS Comparison

AVDL vs VLRS Comparison

Compare AVDL & VLRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVDL
  • VLRS
  • Stock Information
  • Founded
  • AVDL 2015
  • VLRS 2005
  • Country
  • AVDL Ireland
  • VLRS Mexico
  • Employees
  • AVDL N/A
  • VLRS N/A
  • Industry
  • AVDL Biotechnology: Pharmaceutical Preparations
  • VLRS Air Freight/Delivery Services
  • Sector
  • AVDL Health Care
  • VLRS Consumer Discretionary
  • Exchange
  • AVDL Nasdaq
  • VLRS Nasdaq
  • Market Cap
  • AVDL 784.6M
  • VLRS 636.8M
  • IPO Year
  • AVDL 1996
  • VLRS N/A
  • Fundamental
  • Price
  • AVDL $9.46
  • VLRS $4.07
  • Analyst Decision
  • AVDL Strong Buy
  • VLRS Strong Buy
  • Analyst Count
  • AVDL 7
  • VLRS 6
  • Target Price
  • AVDL $18.86
  • VLRS $10.25
  • AVG Volume (30 Days)
  • AVDL 1.2M
  • VLRS 2.0M
  • Earning Date
  • AVDL 05-07-2025
  • VLRS 04-28-2025
  • Dividend Yield
  • AVDL N/A
  • VLRS N/A
  • EPS Growth
  • AVDL N/A
  • VLRS N/A
  • EPS
  • AVDL N/A
  • VLRS 0.04
  • Revenue
  • AVDL $194,450,000.00
  • VLRS $3,052,000,000.00
  • Revenue This Year
  • AVDL $50.53
  • VLRS $4.46
  • Revenue Next Year
  • AVDL $32.33
  • VLRS $15.63
  • P/E Ratio
  • AVDL N/A
  • VLRS $11.39
  • Revenue Growth
  • AVDL 252.64
  • VLRS N/A
  • 52 Week Low
  • AVDL $6.38
  • VLRS $3.53
  • 52 Week High
  • AVDL $17.85
  • VLRS $9.00
  • Technical
  • Relative Strength Index (RSI)
  • AVDL 65.93
  • VLRS 38.27
  • Support Level
  • AVDL $8.55
  • VLRS $3.90
  • Resistance Level
  • AVDL $9.98
  • VLRS $4.19
  • Average True Range (ATR)
  • AVDL 0.50
  • VLRS 0.25
  • MACD
  • AVDL 0.11
  • VLRS 0.05
  • Stochastic Oscillator
  • AVDL 77.73
  • VLRS 41.80

About AVDL Avadel Pharmaceuticals plc

Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.

About VLRS Controladora Vuela Compania de Aviacion S.A.B. de C.V.

Controladora Vuela Compania de Aviacion SAB de CV is a low-cost airline flying to Mexico, the United States, Central and South America. It currently operates up to 500 average daily flight segments on routes that connect 44 cities in Mexico as well as 22 cities in the United States, four in Central America and two in South America. It uses promotional fares to stimulate demand and the base fares are priced to compete with long-distance bus fares in Mexico. Revenues from the air transportation of passengers are recognized earlier when the service is provided or when the non-refundable ticket expires at the date of the scheduled travel. Non-passenger revenues include revenues generated from other non-passenger revenues and cargo services.

Share on Social Networks: